Ms Sarah Butler – PwC Australia Health Leader
Sarah Butler is a Senior Advisor to Executives in Health and Insurance for Strategy&, PwC’s strategy consulting group. She has been with the firm for over 25 years including 20 years in Australia (based in Sydney) and 5 years in China (based in Shanghai). Sarah leads the PwC Australia Health practice, including work with federal and state health departments, insurers, private sector players, NFPs and industry bodies. She also leads the SE Asia and NZ Health Consulting business and supports across the Asia-Pacific region on health and insurance strategy.
PwC support clients to build trust in society and solve important problems, combining capabilities from “strategy through execution” including strategy, organisation, operations, analytics, digital and technology, experience, cyber, risk, financial advisory (M&A, due diligence, tax and legal) and assurance. Previously she was Chairman and MD for Strategy& in Greater China and led PwC’s Management Consulting business, as well as leading our Healthcare, Life Sciences and Insurance Strategy practice in China and the region more broadly. She has experience in each of insurance, hospitals and pharma/medical devices including working at an industry-wide level. She personally advises clients on strategy and transformation. She is a recognized thought leader, authoring a range of publications including Reimagining Health Reform: taking a systems approach to health and wellness; Australia’s healthcare system: an opportunity for economic growth; China Healthcare 2020 and Strategies for the New China Landscape.
Previously, Sarah was a Board Director for two years on the Booz & Company global board and Chair of the Audit Committee in the lead up to our combination with PwC. She continues to serve on global governance committees.
Sarah was a scholar at Christ’s College, Cambridge and received a BA Hons & MA in Natural Sciences (Chemistry). Sarah is also a Graduate of the Australian Institute of Company Directors. She was appointed to the UTS China Research Centre Advisory Board.